AVINGTRANS PLC — Share Issue/Capital Change 2016

Jul 1, 2016

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 0227D

Avingtrans PLC

01 July 2016

Avingtrans Plc

("Avingtrans" or the "Company" or the "Group")

Exercise of Share Options

Avingtrans (AIM:AVG), a manufacturer of critical components and associated services to the global aerospace, energy and medical sectors announces that on 1 July 2016 the Company was notified of the exercise of 60,267 options over ordinary shares of 5p each in the Company ("Ordinary Shares") to certain directors, of which 60,000 options have an exercise price of 96 pence and 267 options have an exercise price of 39.5 pence.

Details of the exercise of options by certain directors of the Company and the subsequent beneficial holdings of such directors following these transactions is set out below:

Director	Number of Options exercised at 96p	Number of Options exercised at 39.5p	Beneficial interest in Ordinary Shares after the transaction
Stephen McQuillan	30,000	-	360,566
Stephen King	30,000	267	316,338

Pursuant to the above transactions, Avingtrans announces that 60,267 ordinary shares of 5p each in the Company have been allotted. Application has been made to the London Stock Exchange for the new ordinary shares to be admitted to trading on AIM and it is expected that admission will take place on 7 July 2016. The new ordinary shares will rank pari passu with the existing shares of the Company.

After admission of these new shares, the Company's total issued share capital is 27,814,831 Ordinary Shares. Avingtrans does not hold any Ordinary Shares in treasury. Therefore, the total number of voting rights in Avingtrans is 27,814,831.

The above figure 27,814,831  may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Avingtrans under the FSA's Disclosure and Transparency Rules.

Enquiries:

Avingtrans plc Steve McQuillan, CEO Stephen King, CFO	0115 949 9020
Numis Securities Limited Tom Ballard (Corporate Broking) Richard Thomas (Corporate Finance and Nominated Adviser)	020 7260 1000
Newgate (Financial PR) Adam Lloyd Ed   Treadwell	020 7653 9850

About Avingtrans

Avingtrans plc is engaged in the provision of highly engineered components, systems and services to the energy, medical and traffic management industries worldwide.

	Energy and medical, engaged in the design and manufacture of safety critical equipment for the energy, medical, science and research communities, including oil and gas extraction and processing equipment, nuclear process plant, machined and fabricated pressure and vacuum vessels and components. Also, design and manufacture of fabricated poles and cabinets for roadside safety cameras and rail track signalling. The strategy of the group, is to "buy and build" in regulated engineering niche markets, where we can see potential consolidation opportunities, which can lead to significantly increased shareholder value over the medium to long term.

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHEADXFEFXKEFF

//<![CDATA[$.ajaxSetup({headers: {'__RequestVerificationToken':'Ev1EAJLVLIUd7VeEI_rk-VTle-zd9-VZpnfXyZytcuF5dJMLi6nq7wppB0MWpZbZztTgE4A2v_Nk4djChUHJoXX9kWAmJfmmDkkphV4iP6U1:hZyg0wBFJsxcPgomvgB15Zcr37QGHcogck6blsISGTO_BnCgRtEq4O5iL_hl8AmCeY8LU0pbFak-Mm0ygMhrSnGl0v-5XfKMLRbcgDNxwx01'}});//]]>